Adamis Pharmaceuticals Corp ADMP Income Statement

Adamis pharmaceuticals corp (ADMP)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10
REVENUE, net
4,663	5,540	5,902	5,764	4,905	4,153	3,832	3,920	3,179	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	0	0	0	-	-	0	0	0	0	0	0
REVENUE, net
-	-	-	-	-	-	-	-	-	-	3,388	3,805	3,037	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
REVENUE, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,075	1,928	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
COST OF GOODS SOLD
-	-	-	-	-	-	-	-	-	-	2,092	1,881	1,664	-	1,821	1,346	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
COST OF GOODS SOLD
3,687	4,198	3,988	3,665	3,625	3,039	2,300	2,394	2,063	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Gross Profit
976	1,341	1,914	2,099	1,280	1,113	1,532	1,526	1,116	1,060	1,295	1,923	1,373	-	254	582	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES
6,054	4,965	5,300	7,000	8,021	6,576	6,534	6,362	6,473	5,843	5,747	5,655	5,572	4,592	5,335	4,583	2,616	1,826	2,125	2,261	2,793	2,201	1,343	1,010	1,335	776	762	515	547	541	429	488	353	807	906	582	352	928	1,095	989
RESEARCH AND DEVELOPMENT
2,036	2,014	3,318	2,845	2,196	7,800	3,908	4,835	2,249	3,582	1,248	1,185	1,509	1,372	1,494	3,429	3,400	1,035	1,182	1,269	1,355	1,207	597	1,740	378	208	194	224	346	205	421	235	779	181	573	630	766	2,092	17	0
IMPAIRMENT EXPENSE
3,143	-	303	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
LOSS ON IMPAIRMENT OF FIXED ASSETS
-	-	-	-	-	-	-	-	-	-	96	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from Operations
-10,258	-5,657	-7,008	-7,746	-8,937	-13,273	-8,910	-9,672	-7,606	-8,366	-5,796	-4,917	-5,709	-5,181	-6,575	-7,430	-6,017	-2,862	-3,307	-3,531	-4,148	-3,409	-1,941	-2,750	-1,714	-984	-957	-739	-893	-747	-851	-724	-1,133	-988	-1,480	-1,212	-1,118	-3,021	-1,112	-989
OTHER INCOME (EXPENSE)
Interest Expense
38	54	21	22	24	25	30	51	50	51	52	59	67	-	70	72	-	-	-	-	-	0	0	225	145	5,298	2,777	404	614	845	579	294	2	2	2	27	31	72	318	322
Interest Income
23	36	30	34	74	118	66	21	39	53	39	5	4	-	1	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inducement Expense for Exercise of Warrants
-	-	-	-	-	-	-	-	-	-	960	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain on Extinguishment of Debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	198	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in Fair Value of Warrant Liability
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-1,432	382	705	-139	92	-1,092	1,019	626	-591	-126	769	-1,404	-	-	0	-	-	-	-	-	-	-	-	-	-
Gain on Sale of Asset
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5	-	-	-	-	-
Change in Fair Value of Warrant Derivative Liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	356	-8	-68	19	-21	-84	118	442	-496	-18	-	0	-	-	-	-	-	-	-	0	0	-	-	-	-
Gain on Sale of Asset
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0	5	-
Change in Fair Value of Derivative Liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-18	1,141	-244	40	-29	-16	-105	28	-	-	-	-	-	-	-	-
Change in Fair Value of Conversion Feature Liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	381	2,542	61	30	-364	678	-1,735	-	-	-	-	-	-	-	-
Change in Fair Value of Warrants Liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-
Change in Fair Value of Derivative Liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-
Change in Fair Value of Conversion Feature Liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-
Change in Fair Value of Conversion Feature Liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-
Total Other Income (Expense), net
-15	-17	8	11	50	93	35	-29	-11	1	-973	-54	-63	-63	-68	1,716	-391	-774	159	-113	1,007	-900	-183	-130	162	-4,544	925	-302	-613	-1,226	-6	-2,001	-2	-2	2	-27	-	-	-	-
Net (Loss)
-10,273	-5,684	-6,999	-7,735	-8,887	-12,810	-8,875	-9,702	-7,618	-8,025	-6,769	-4,971	-5,772	-670	-6,644	-5,714	-6,408	-3,637	-3,148	-3,644	-3,141	-4,310	-2,124	-2,881	-1,552	-5,529	-31	-1,042	-1,636	-1,974	-857	-2,726	-1,205	-991	-1,477	-1,240	-	-3,093	-	-
Deemed Dividend on Preferred Stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,374	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net (Loss) Applicable to Common Stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-8,018	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,425	-1,311
Basic and Diluted (Loss) Per Share
Basic and Diluted (Loss) Per Share (in dollars per share)
-0.15	-0.08	-0.12	-0.16	-0.19	-0.27	-0.21	-0.29	-0.23	-0.24	-0.21	-0.19	-0.26	0.07	-0.41	-0.37	-0.48	-	-	-	-	-	-	-	-	-0.82	0.00	-0.17	-	-0.34	-0.01	-0.03	-0.01	-0.01	-0.02	-0.02	0.02	-0.04	-0.05	-0.04
Basic and Diluted Weighted Average Shares Outstanding (in shares)
66,499	61,921	56,283	47,539	47,311	47,477	42,085	33,389	33,389	33,549	31,509	26,221	22,118	21,579	19,606	15,373	13,444	-	-	-	-	-	-	-	-	6,741	6,169	6,144	-	5,810	98,293	97,206	94,021	91,885	89,698	82,305	123,721	70,005	31,614	29,804
Basic (Loss) Per Share
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.28	-0.23	-0.27	-0.24	-0.42	-0.20	-0.27	-0.15	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic Weighted Average Shares Outstanding
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,438	13,420	13,415	12,828	10,564	10,514	10,500	10,384	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (Loss) Per Share
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.20	-0.24	-0.27	-0.32	-0.42	-0.20	-0.27	-0.16	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted Weighted Average Shares Outstanding
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,740	13,504	13,415	13,086	10,564	10,514	10,500	10,447	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-